Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea

Sleep

Volumn 25, Issue 1, 2002, Pages 59-65

  Gozal, David ^a   Lipton, Andrew J ^a   Jones, Kimberly L ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar hypoventilation; Arousal; Intermittent hypoxia; Sleep apnea; Sleepiness

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; APNEA; ARTICLE; CHILD; CORRELATION ANALYSIS; DYSPNEA; FEMALE; HUMAN; HYPOXIA; LABORATORY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SLEEP APNEA SYNDROME; UNIVERSITY HOSPITAL;

EID: 0036467294     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/25.1.59     Document Type: Article

References (35)

1. Vascular endothelial growth factor in exercising humans under different environmental conditions
2. Systemic hypoxia changes the organ specific distribution of vascular endothelial growth factor and its receptors
3. Vascular Endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke
4. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
5. Increased gene expression for VEGF and the VEGF receptors KDR/FLK and FLT in lungs exposed to acute and chronic hypoxia
6. Rat brain expression in alveolar hypoxia: Possible role in high altitude cerebral edema
7. Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease
8. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tissue patients
9. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
10. Circulating vascular endothelial growth factors in patients with colorectal cancer
11. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
12. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema
13. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension
14. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome
15. Sleep-disordered breathing and school performance in children
16. Standards and indications for cardiopulmonary sleep studies in children
17. Normal polysomnographic values for children and adolescents
18. Normal oxyhemoglobin saturation during sleep. How low does it go?
19. Cardiorespiratory sleep studies in children: Establishment of normative data and polysomnographic predictors of morbidity
20. EEG arousals: Scoring rules and examples
21. Users' guides to the medical literature III How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?
22. Nomogram for Bayes theorem
23. Likelihood ratios: Getting diagnostic testing into perspective
24. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation
25. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
26. Major surgery increases serum levels of vascular endothelial growth factor only temporarily
27. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 α ? in vascular smooth muscle cells
28. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
29. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
30. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?
31. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood
32. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
33. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
34. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity